Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2021 Aug 27

PMID 34440306

Citations 22

Authors

Emel Rothzerg

Xuan Dung Ho

Jiake Xu

David Wood

Aare Martson

Sulev Koks

Affiliations

Soon will be listed here.

Abstract

The human genome encodes thousands of natural antisense long noncoding RNAs (lncRNAs); they play the essential role in regulation of gene expression at multiple levels, including replication, transcription and translation. Dysregulation of antisense lncRNAs plays indispensable roles in numerous biological progress, such as tumour progression, metastasis and resistance to therapeutic agents. To date, there have been several studies analysing antisense lncRNAs expression profiles in cancer, but not enough to highlight the complexity of the disease. In this study, we investigated the expression patterns of antisense lncRNAs from osteosarcoma and healthy bone samples (24 tumour-16 bone samples) using RNA sequencing. We identified 15 antisense lncRNAs (, , , , , , , , , , , , , and ) that were upregulated in tumour samples compared to bone sample controls. Further, we performed real-time polymerase chain reaction (RT-qPCR) to validate the expressions of the antisense lncRNAs in 8 different osteosarcoma cell lines (SaOS-2, G-292, HOS, U2-OS, 143B, SJSA-1, MG-63, and MNNG/HOS) compared to hFOB (human osteoblast cell line). These differentially expressed IncRNAs can be considered biomarkers and potential therapeutic targets for osteosarcoma.

Citing Articles

OTUD6B-AS1: a multifaceted regulator of cancer with critical clinical implications.

Zheng Z, Zhou C, Yi F, Li J Am J Cancer Res. 2025; 15(1):1-18.

PMID: 39949926 PMC: 11815388. DOI: 10.62347/EHQK5961.

Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response.

Fischer K, Tiwari S, Thier B, Qiu L, Lin T, Paschen A Front Mol Biosci. 2024; 11:1471100.

PMID: 39398277 PMC: 11466874. DOI: 10.3389/fmolb.2024.1471100.

The Pivotal Function of SLC16A1 and SLC16A1-AS1 in Cancer Progress: Molecular Pathogenesis and Prognosis.

Zhou Y, Tan F, Wang Z, Zhou G, Yuan C Mini Rev Med Chem. 2024; 24(18):1685-1700.

PMID: 38616756 DOI: 10.2174/0113895575284780240327103039.

Advances in prognostic models for osteosarcoma risk.

Yao Y, Wang D, Zheng L, Zhao J, Tan M Heliyon. 2024; 10(7):e28493.

PMID: 38586328 PMC: 10998144. DOI: 10.1016/j.heliyon.2024.e28493.

Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response.

Gao M, Wang M, Chen Y, Wu J, Zhou S, He W J Cancer Res Clin Oncol. 2024; 150(4):171.

PMID: 38558328 PMC: 10984901. DOI: 10.1007/s00432-024-05665-x.

References

Prensner J, Chinnaiyan A . The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1(5):391-407. PMC: 3215093. DOI: 10.1158/2159-8290.CD-11-0209. View

Dong J, Wang R, Ren G, Li X, Wang J, Sun Y . HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer. Clin Cancer Res. 2017; 23(13):3461-3473. DOI: 10.1158/1078-0432.CCR-16-2180. View

Ros G, Pegoraro S, De Angelis P, Sgarra R, Zucchelli S, Gustincich S . HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion. Front Oncol. 2020; 9:1526. PMC: 6978849. DOI: 10.3389/fonc.2019.01526. View

Wu C, Beird H, Livingston J, Advani S, Mitra A, Cao S . Immuno-genomic landscape of osteosarcoma. Nat Commun. 2020; 11(1):1008. PMC: 7035358. DOI: 10.1038/s41467-020-14646-w. View

Lamplot J, Denduluri S, Qin J, Li R, Liu X, Zhang H . The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev. 2016; 9(1):55-77. PMC: 4730918. DOI: 10.2174/1573394711309010006. View

Balbin O, Malik R, Dhanasekaran S, Prensner J, Cao X, Wu Y . The landscape of antisense gene expression in human cancers. Genome Res. 2015; 25(7):1068-79. PMC: 4484389. DOI: 10.1101/gr.180596.114. View

Esquenet M, Swinnen J, Heyns W, Verhoeven G . LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. J Steroid Biochem Mol Biol. 1997; 62(5-6):391-9. DOI: 10.1016/s0960-0760(97)00054-x. View

Song N, Shin A, Park J, Kim J, Oh J . Common risk variants for colorectal cancer: an evaluation of associations with age at cancer onset. Sci Rep. 2017; 7:40644. PMC: 5233996. DOI: 10.1038/srep40644. View

Sambuy Y, De Angelis I, Ranaldi G, Scarino M, Stammati A, Zucco F . The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005; 21(1):1-26. DOI: 10.1007/s10565-005-0085-6. View

10.

Li Y, Qiang W, Griffin B, Gao T, Chakravarti D, Bulun S . HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma. Fertil Steril. 2020; 114(5):1085-1096. PMC: 7655683. DOI: 10.1016/j.fertnstert.2020.05.036. View

11.

Ponting C, Oliver P, Reik W . Evolution and functions of long noncoding RNAs. Cell. 2009; 136(4):629-41. DOI: 10.1016/j.cell.2009.02.006. View

12.

Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Jarvinen H, Mecklin J . SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res. 2005; 11(7):2606-11. DOI: 10.1158/1078-0432.CCR-04-1458. View

13.

Manandhar M, Boulware K, Wood R . The ERCC1 and ERCC4 (XPF) genes and gene products. Gene. 2015; 569(2):153-61. PMC: 4536074. DOI: 10.1016/j.gene.2015.06.026. View

14.

van der Pluijm I, Garinis G, Brandt R, Gorgels T, Wijnhoven S, Diderich K . Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol. 2007; 5(1):e2. PMC: 1698505. DOI: 10.1371/journal.pbio.0050002. View

15.

Modi A, Vai S, Caramelli D, Lari M . The Illumina Sequencing Protocol and the NovaSeq 6000 System. Methods Mol Biol. 2021; 2242:15-42. DOI: 10.1007/978-1-0716-1099-2_2. View

16.

Finley J, Newman S . The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med. 1997; 214(3):248-57. DOI: 10.3181/00379727-214-44093. View

17.

Dey B, Mueller A, Dutta A . Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014; 5(4):e944014. PMC: 4581346. DOI: 10.4161/21541272.2014.944014. View

18.

Wang X, Wang J, Wu J . Emerging roles for HMGA2 in colorectal cancer. Transl Oncol. 2020; 14(1):100894. PMC: 7563012. DOI: 10.1016/j.tranon.2020.100894. View

19.

Hangauer M, Vaughn I, McManus M . Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 2013; 9(6):e1003569. PMC: 3688513. DOI: 10.1371/journal.pgen.1003569. View

20.

Geisler S, Coller J . RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013; 14(11):699-712. PMC: 4852478. DOI: 10.1038/nrm3679. View